Effect of OCT B-Scan Density on Sensitivity for Detection of Intraretinal Hyperreflective Foci in Eyes with Age-Related Macular Degeneration.
AMD
IHRF
Intraretinal hyperreflective foci
OCT
SD-OCT
age-related macular degeneration
retinal diseases
Journal
Current eye research
ISSN: 1460-2202
Titre abrégé: Curr Eye Res
Pays: England
ID NLM: 8104312
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
pubmed:
24
5
2022
medline:
30
8
2022
entrez:
23
5
2022
Statut:
ppublish
Résumé
To evaluate the impact of reducing the density of B-scans in an optical coherence tomography (OCT) volume on the sensitivity for detecting intraretinal hyperreflective foci (IHRF) in eyes with intermediate age-related macular degeneration (AMD). A total of 165 eyes with intermediate AMD and IHRF were evaluated in this retrospective analysis. For each case, Cirrus HD-OCT volumes were imported into the reading center 3 D-OCTOR software. The number of IHRF cases was assessed based on all 128 B-scans (spaced 47 μm apart), using a categorical scale (graded as 1-4, 5-9, 10-14, 15-19, and >20). Additionally, the B-scan densities in the volume were lowered to 64 B-scans (spaced 94 μm apart), 43 B-scans (spaced 140 μm apart), and 32 B-scans (spaced 188 μm apart). The number of eyes with any IHRF and the numerical category of IHRF in the eye were used to compare the sensitivity at each reduced B-scan density against the reference 128 B-scan volume. In the primary analysis for the qualitative presence or absence of any IHRF, the sensitivity decreased to 98.2% ( Increasing the inter-B-scan spacing from 47 to 188 microns significantly reduced the ability to accurately determine whether IHRF were present in an eye. An increase in inter-B-scan spacing to 140 microns was associated with a significant misclassification of the IHRF quantity. These findings may be relevant in the design of OCT scanning protocols for studies utilizing these biomarkers for AMD progression.
Identifiants
pubmed: 35603911
doi: 10.1080/02713683.2022.2081981
pmc: PMC10350297
mid: NIHMS1911843
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1294-1299Subventions
Organisme : NEI NIH HHS
ID : R01 EY023164
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY030614
Pays : United States
Références
Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3431-3439
pubmed: 30025092
Ophthalmology. 2019 Dec;126(12):1667-1674
pubmed: 31281056
Acta Ophthalmol. 2012 Jun;90(4):e274-80
pubmed: 22429902
Can J Ophthalmol. 2021 Oct;56(5):325-334
pubmed: 33539821
Prog Retin Eye Res. 2008 Jan;27(1):45-88
pubmed: 18036865
Ophthalmologica. 2013;229(1):32-7
pubmed: 23006969
Ophthalmology. 2013 Dec;120(12):2656-2665
pubmed: 23830761
JAMA Ophthalmol. 2020 Jul 1;138(7):740-747
pubmed: 32379287
Eye (Lond). 2017 Jan;31(1):53-61
pubmed: 27911444
Retina. 2019 Aug;39(8):1540-1550
pubmed: 29746403
Invest Ophthalmol Vis Sci. 2005 Mar;46(3):974-8
pubmed: 15728555
Invest Ophthalmol Vis Sci. 2010 Feb;51(2):1071-8
pubmed: 19797199
Ophthalmology. 2013 May;120(5):1038-45
pubmed: 23352193
Graefes Arch Clin Exp Ophthalmol. 2017 Aug;255(8):1551-1558
pubmed: 28534244
Arch Ophthalmol. 2003 Nov;121(11):1621-4
pubmed: 14609922
Invest Ophthalmol Vis Sci. 2007 Feb;48(2):839-48
pubmed: 17251486
Arch Ophthalmol. 2005 Nov;123(11):1570-4
pubmed: 16286620
Ophthalmology. 2006 Feb;113(2):285-93
pubmed: 16406542
Arch Ophthalmol. 2005 Nov;123(11):1484-98
pubmed: 16286610
Invest Ophthalmol Vis Sci. 2016 Apr;57(4):1839-46
pubmed: 27082298
Retina. 2015 Apr;35(4):638-47
pubmed: 25650713
Ophthalmology. 2011 Apr;118(4):687-93
pubmed: 21093923
Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO211-BIO226
pubmed: 28785769
J Clin Med. 2015 Mar;4(3):424-40
pubmed: 25905023